ClinicalTrials.Veeva

Menu

Development and Validation of the GLORI-COPD Score

U

University of Paris 5 - Rene Descartes

Status

Active, not recruiting

Conditions

Pulmonary Disease, Chronic Obstructive

Study type

Observational

Funder types

Other

Identifiers

NCT04027296
2018-A03259-46

Details and patient eligibility

About

The objective of this study is to evaluate the diagnostic accuracy of the GLORI-COPD score in ambulatory care, to enable the screening of COPD patients at risk of complications, requiring early management

Full description

Chronic obstructive pulmonary disease (COPD) is a chronic disease with a high prevalence in France, but which remains under-diagnosed due to the trivialization of symptoms and difficulty in accessing diagnostic investigations. It is associated with other co-morbidities, with an impact on the occurrence of complications and quality of life. Early management of the most severe patients would allow better control of these risks of complications. Our objective is to better identify patients with COPD at risk of complications in general practice, taking into account the totality of the patient, to improve their management.

Enrollment

462 patients

Sex

All

Ages

35+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥ 35 yo
  • smoker or former smoker ≥ 10 Pack Years

Exclusion criteria

  • Patients who have already been diagnosed with COPD by spirometry,
  • have a contraindication to spirometry,
  • have an estimated life expectancy of less than 5 years
  • are under protective measures

Trial design

462 participants in 1 patient group

suspected COPD
Description:
Patients aged ≥ 35yo and ≥10Pack.Year

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems